Nothing Special   »   [go: up one dir, main page]

AUPP259898A0 - EGF receptor family agonists and antagonists - Google Patents

EGF receptor family agonists and antagonists

Info

Publication number
AUPP259898A0
AUPP259898A0 AUPP2598A AUPP259898A AUPP259898A0 AU PP259898 A0 AUPP259898 A0 AU PP259898A0 AU PP2598 A AUPP2598 A AU PP2598A AU PP259898 A AUPP259898 A AU PP259898A AU PP259898 A0 AUPP259898 A0 AU PP259898A0
Authority
AU
Australia
Prior art keywords
antagonists
receptor family
egf receptor
agonists
family agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP2598A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Priority to AUPP2598A priority Critical patent/AUPP259898A0/en
Publication of AUPP259898A0 publication Critical patent/AUPP259898A0/en
Priority to AU15521/99A priority patent/AU749992B2/en
Priority to DE69834828T priority patent/DE69834828T2/en
Priority to EP98959677A priority patent/EP1034188B1/en
Priority to JP2000523238A priority patent/JP2001525339A/en
Priority to AT98959677T priority patent/ATE328903T1/en
Priority to PCT/AU1998/000998 priority patent/WO1999028347A1/en
Priority to CA002311926A priority patent/CA2311926A1/en
Priority to US09/555,275 priority patent/US7020563B1/en
Abandoned legal-status Critical Current

Links

AUPP2598A 1997-11-27 1998-03-25 EGF receptor family agonists and antagonists Abandoned AUPP259898A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
AUPP2598A AUPP259898A0 (en) 1998-03-25 1998-03-25 EGF receptor family agonists and antagonists
AU15521/99A AU749992B2 (en) 1997-11-27 1998-11-27 Method of designing agonists and antagonists to IGF receptor
DE69834828T DE69834828T2 (en) 1997-11-27 1998-11-27 PROCESS FOR THE CONSTRUCTION OF AGONISTS AND ANTAGONISTS OF THE IGF RECEPTOR (1-462)
EP98959677A EP1034188B1 (en) 1997-11-27 1998-11-27 Method of designing agonists and antagonists to igf receptor (1-462)
JP2000523238A JP2001525339A (en) 1997-11-27 1998-11-27 Method for designing agonists and antagonists to IGF receptor
AT98959677T ATE328903T1 (en) 1997-11-27 1998-11-27 METHOD FOR CONSTRUCTING AGONISTS AND ANTAGONISTS OF THE IGF RECEPTOR (1-462)
PCT/AU1998/000998 WO1999028347A1 (en) 1997-11-27 1998-11-27 Method of designing agonists and antagonists to igf receptor
CA002311926A CA2311926A1 (en) 1997-11-27 1998-11-27 Method of designing agonists and antagonists to igf receptor
US09/555,275 US7020563B1 (en) 1997-11-27 1998-11-27 Method of designing agonists and antagonists to IGF receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP2598A AUPP259898A0 (en) 1998-03-25 1998-03-25 EGF receptor family agonists and antagonists

Publications (1)

Publication Number Publication Date
AUPP259898A0 true AUPP259898A0 (en) 1998-04-23

Family

ID=3806859

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP2598A Abandoned AUPP259898A0 (en) 1997-11-27 1998-03-25 EGF receptor family agonists and antagonists

Country Status (1)

Country Link
AU (1) AUPP259898A0 (en)

Similar Documents

Publication Publication Date Title
AU5203999A (en) Beta3-adrenergic receptor agonists
AU1772300A (en) Glucagon antagonists/inverse agonists
AU3213799A (en) Integrin antagonists
AU2764797A (en) Somatostatin agonists and antagonists
EG23913A (en) Estrogen agonists / antagonists
AU4698299A (en) 5-HT7 receptor antagonists
AUPP380498A0 (en) Egf receptor agonists and antagonists
AU8689798A (en) Integrin receptor antagonists
AU2242197A (en) Benzimidzolyl neuropeptide y receptor antagonists
AU1926000A (en) Pth1r and pth3r receptors
AU4772497A (en) Constrained somatostatin agonists and antagonists
IL141050A0 (en) Muscarinic agonists and antagonists
AU1403099A (en) Alpha-1a adrenergic receptor antagonists
AU4961499A (en) 5-HT1f agonists
AU5861900A (en) Receptor agonists and antagonists
AU4980999A (en) A3 adenosine receptor antagonists
AU2001225663A1 (en) A composition comprising a combination of receptor agonists and antagonists
EP1137938A4 (en) Methods of screening for agonists and antagonists of the hdpxu17 receptor
GB9820014D0 (en) Receptor antagonists and uses thereof
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
AU6826598A (en) Endothelin-receptor antagonists
AU3935897A (en) B1-bradykinin receptor antagonists and use thereof
AU5112699A (en) 5-HT1f antagonists
IL137428A0 (en) Estrogen agonists and antagonists for multiple indications
IL131274A0 (en) Estrogen agonists/antagonists